Armed with what CEO Robert Davis called the “broadest and widest pipeline we’ve had in years,” Merck is preparing for its ...
Merck posted a modest 2026 outlook that fell short of estimates, as it prepares for some drugs to go off patent later this ...
Merck’s stock falls as the full-year revenue and profit outlooks were below expectations.
Feb 3 (Reuters) - Medtronic said on Tuesday it would buy privately held CathWorks in a deal valued at up to $585 million, as ...
On January 15, 2026, President Trump called on Congress to enact The Great Healthcare Plan, which would lower drug prices by codifying the savings from his Most-Favored-Nation pricing initiative, ...
Vaccine makers are seeing sales declines in the U.S. and upswings in Europe. Elsewhere, investors fretted over an AbbVie ...
On Tuesday, Medtronic announced intent to acquire CathWorks, an Israel-based medical technology company, for $585 million. CathWorks has its U.S. headquarters in California and specializes in ...
DelveInsight's Insulin Resistance Market Insights report includes a comprehensive understanding of current treatment practices, insulin resistance emerging drugs, market share of individual therapies, ...
Geoffrey Seiler is a contributing Motley Fool stock market analyst covering technology, consumer goods, healthcare, energy, and materials stocks. Prior to The Motley Fool, Geoffrey was a senior equity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results